Alleva Lawrence M

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$360,847.78
Insider Sells Quantity
2
Insider Sells Sum
$903,399.00
2023-12-01SaleBright Horizons Family Solutions Inc.
BFAM
director
680
0.0012%
$88.58$60,238+24.47%
2021-06-01PurchaseAdaptimmune Therapeutics plc
ADAP
director
12,600
0.0013%
$0.79$9,954-23.24%
2021-06-01PurchaseMersana Therapeutics, Inc.
MRSN
director
2,070
0.003%
$14.38$29,767-53.4%
2020-06-09PurchaseAdaptimmune Therapeutics plc
ADAP
director
12,900
0.0016%
$1.89$24,381-49.33%
2020-06-01PurchaseMersana Therapeutics, Inc.
MRSN
director
2,170
0.0039%
$22.95$49,803-8.18%
2020-05-19PurchaseBright Horizons Family Solutions Inc.
BFAM
director
227
0.0004%
$107.95$24,505+48.29%
2018-12-17PurchaseAdaptimmune Therapeutics plc
ADAP
director
94,560
0.0185%
$0.84$79,430-17.61%
2018-08-07SaleBright Horizons Family Solutions Inc.
BFAM
director
7,672
0.0134%
$109.90$843,161+10.56%
2013-11-12PurchaseBright Horizons Family Solutions Inc.
BFAM
director
2,800
0.0045%
$35.36$99,008+14.12%
2013-01-30PurchaseBright Horizons Family Solutions Inc.
BFAM
director
2,000
0.0028%
$22.00$44,000+23.18%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.